Novartis Aktie
98,72
EUR
-0,68
EUR
-0,68
%
91,55
CHF
-0,74
CHF
-0,80
%
Werbung
Novartis Aktie Analyse
| 15.09.22 | Novartis Underperform | Credit Suisse Group | |
| 14.09.22 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.08.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.08.22 | Novartis Neutral | UBS AG | |
| 25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 20.07.22 | Novartis Neutral | Credit Suisse Group | |
| 20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.22 | Novartis Sell | Deutsche Bank AG | |
| 19.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.22 | Novartis Neutral | UBS AG | |
| 19.07.22 | Novartis Buy | Jefferies & Company Inc. | |
| 18.07.22 | Novartis Underweight | Barclays Capital | |
| 15.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 13.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.07.22 | Novartis Neutral | UBS AG | |
| 30.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.06.22 | Novartis Sell | Deutsche Bank AG | |
| 22.06.22 | Novartis Neutral | UBS AG | |
| 22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.06.22 | Novartis Sell | Deutsche Bank AG | |
| 27.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | Novartis Neutral | Credit Suisse Group | |
| 27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.22 | Novartis Neutral | UBS AG | |
| 27.04.22 | Novartis Sell | Deutsche Bank AG | |
| 26.04.22 | Novartis Neutral | UBS AG | |
| 26.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 26.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 08.04.22 | Novartis Neutral | UBS AG | |
| 05.04.22 | Novartis Sell | Deutsche Bank AG | |
| 04.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.03.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.03.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.03.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Equal-weight | Morgan Stanley | |
| 03.02.22 | Novartis Neutral | UBS AG | |
| 03.02.22 | Novartis Sell | Deutsche Bank AG | |
| 03.02.22 | Novartis Neutral | Credit Suisse Group | |
Werbung
Werbung